POST FALLS, Idaho, March 14, 2019 /PRNewswire/ -- Northwest

New Post Public Reply Private Reply Replies (0) Message Board
iwantutowantBIEL
273
POST FALLS, Idaho, March 14, 2019 /PRNewswire/ -- Northwest Specialty Hospital is proud to announce that they are offering electroceutical devices as an alternative to opioid medication for pain management in conjunction with RiversEdge Orthopedics, Axis Spine and Bioelectronics Corporation (OTC PINK: BIEL).
Error! Filename not specified.
According to the National Institute on Drug Abuse, "Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare."
Post-surgical pain is reported by approximately 80% of patients following an operation and opioids are a common treatment option chosen by patients suffering from post-surgical pain. In light of the growing epidemic of opioid abuse, dependence and overdose in the United States, exploration of alternative therapeutic options to reduce potential exposure to opioids, Northwest Specialty Hospital feels compelled to explore non-pharmacologic, FDA approved alternatives to opioids. As such, they are engaged in discussions with Bioelectronics Corporation about the clinical results of their line of bioelectronics devices and were intrigued by both the science and the results behind these bioelectronics devices.
"By introducing innovative non-pharmacologic, non-addictive solutions to pain management, we are changing the way in which we provide care. Working with technologically innovative surgical practices, such as RiversEdge Orthopedics and Axis Spine, provides us with a significant opportunity to help our patients find safe and effective pain relief for our patients," states Northwest Specialty Hospital, CEO,Rick Rasmussen.
Acti-Patch is a wearable, over-the-counter electromagnetic neuromodulation therapy that provides safe and effective relief from postoperative pain and chronic musculoskeletal pain. These devices are FDA cleared and have been used in a series of high-quality clinical trials, many of which have been peer reviewed and published in widely recognized medical journals including Rheumatology, Journal of Foot and Ankle Surgery, Aesthetics of Plastic Surgery and Pain Management.
"We've seen a reduction of pain, as well as a reduction of the use of pain medication for patients who have used the Acti-Patch for trapezius muscle pain, as well as knee pain. We've been pleasantly surprised with the results," says Molly Liter, NP of Axis Spine, LLC.
"Initially, I was a tremendous skeptic of this device. I purchased one online, basically to prove that it would not work. I used it myself and I could not believe how much pain relief I had. I have given out dozens to patients and feel that the response is approximately 80-90% experience relief from superficial pain," says Spencer Greendyke, MD of RiversEdge Orthopedics.
BioElectronics' devices are cleared by the FDA for over-the-counter use and are publicly available on Amazon. To request additional information, please see below:
About Northwest Specialty Hospital
Northwest Specialty Hospital is an award winning, five-star specialty hospital owned and operated by physicians and Surgery Partners, Inc. For more information, please visit: http://www.nwsh.com
About RiversEdge Orthopedics
Located in Coeur d' Alene, Idaho, RiversEdge Orthopedics offers innovative orthopedic care backed by more than 30 years of experience in creating amazing results for their patients. For more information, please visit: http://www.riversedgeortho.com/
About Axis Spine Center
Axis Spine Center is the region's only comprehensive spine center. Our fellowship trained board certified physicians specialize in all aspects of spine care and pain management. We utilize cutting edge and state of the art treatments to get patients back to the life they want to live. For more information, please visit: https://axisspinecenter.com/
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com or call 301-8744890.

Error! Filename not specified.
Error! Filename not specified. View original content to download multimedia:http://www.prnewswire.com/news-releases/northwest-specialty-hospital-now-offering-electroceutical-alternative-to-opioids-in-clinical-practice-300812239.html
SOURCE Northwest Specialty Hospital
Media Contact: Darron Rock, Northwest Specialty Hospital, 1593 E. Polston Avenue, Post Falls, ID 83854, Phone: 208-262-2300, Email: Darron.rock@surgerypartners.com; or Paul Knopick, E & E Communications, 8604 Gardenia Drive, Denton, TX. 76207, Phone: 940-262-3584, E-mail: ir@bielcorp.com

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Chip Earnings Fuel Market Gains Amid Volatility Dip

Updated Category News Views 56

Tech Earnings Drive Market Resilience Amid a climate of economic uncertainty, it's refreshing to see semiconductor and tech earnings offering a little backbone to the market. This week, the S&P 500 climbed 1.51%, while the Nasdaq Composite jumped 1.98% over three sessions. It's like watching Rocky get up off the mat—those indices pushing higher when it seemed like they...

Continue Reading
Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Updated Category News Views 88

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 84

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 123

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 38

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 45

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 76

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading

Top 5 Most Recently Viewed Articles

Sollis Health Welcomes Katy Marshall as Chief Growth Officer

Updated Category News Views 511

Sollis Health Welcomes Katy Marshall as Chief Growth Officer The leading concierge medical provider has appointed Katy Marshall as Chief Growth Officer. With her extensive background in driving growth for consumer and healthcare brands, she will guide the company's marketing, sales, and product strategies. Experienced Leadership Katy brings a wealth of experience to...

Continue Reading
Kulicke & Soffa Delivers Strong Q4 Performance Highlights

Updated Category News Views 153

Strong Financial Performance in Q4 Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) reported impressive financial results for the fourth quarter, showcasing resilience and growth in a challenging market. The company achieved a net revenue of $177.6 million, reflecting its ongoing commitment to innovation and operational efficiency. Lester Wong, the Interim Chief...

Continue Reading
Unlocking Dividend Income: Strategies for Salesforce Investors

Updated Category News Views 85

Understanding Salesforce's Dividend Potential Salesforce, Inc. (NYSE: CRM) is a leading company known for its innovative cloud-based solutions. With its upcoming fourth-quarter financial results, many investors are curious about how to maximize their returns, particularly through dividends. This approach can be an excellent way to create a significant income stream while...

Continue Reading
Investigation Launched into Sage Therapeutics' Recent Drug Trials

Updated Category News Views 93

Introducing Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is a biopharmaceutical company dedicated to developing innovative therapies aimed at enhancing brain health. However, recent events have raised serious concerns among investors, prompting an investigation into possible violations of federal securities laws. Stock Price Affected by Recent Events FDA...

Continue Reading
Genius Group Investors Can Pursue Class Action for Losses

Updated Category News Views 208

Genius Group Limited Faces Class Action Lawsuit Genius Group Limited, recognized by its ticker symbol GNUS, is currently embroiled in a class action lawsuit aimed at addressing significant investor losses. This legal action comes as a response to alleged stock market misconduct by certain trading firms. Investors Encouraged to Take Action The law firm Bronstein, Gewirtz &...

Continue Reading